Immunosuppressive activity of Leishmania major culture supernatant

Iranian Journal of Public Health

Volumn 35, Issue 3, 2006, Pages 22-27

  Abolhassani, M ^a   Darabi, H ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Amastigote; Excretory factor; Immunosuppressive; Leishmania major; Promastigote

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MITOGENIC AGENT;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DOWN REGULATION; GERMFREE ANIMAL; HOST PARASITE INTERACTION; IMMUNE RESPONSE; IMMUNOMODULATION; INCUBATION TIME; INFECTION SENSITIVITY; INTERFERON PRODUCTION; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MOUSE; MOUSE STRAIN; NONHUMAN; PARASITE ISOLATION; PARASITE SURVIVAL; PHAGOLYSOSOME; PROMASTIGOTE; SPLEEN CELL; SUPERNATANT; TH2 CELL;

EID: 33749867190     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Herwaldt BL (1999). Leishmaniasis. Lancet, 354: 1191-99.
2. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Pros Nalt Acad Sci USA, 88: 7011-15.
3. Lewis DH, Peter W (1977). The resistance of intracellular leishmania parasite to digestion by lysosomal enzymes. Ann Trop Med Parasitol, 71: 295-312.
4. El-On J, Schnur LF, Greenblatt CL (1979). Leishmania donovani: physicochemical, immunological and biological characterization of excreted factor from promastigotes. Exp Parasitol, 47: 254-69.
5. Webb JR, Campos-Neto A, Ovendale PJ, Martin TI, Stromberg EJ, Badaro R, et al. (1998). Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multi-copy gene family. Infect Immun, 66: 3279-289.
6. Bates PA, Gottlieb M, Dwyer DM (1998). Leishmania donovani: identification of glycoproteins released by promastigotes during growth in vitro. Exp Parasitol, 67: 199-209.
7. Bates PA, Dwyer DM (1987). Biosynthesis and secretion of acid phosphatase by Leishmania donovani promastigotes. Mol Biochem Parasitol, 26: 289-96.
8. Wiese M, Ilg T, Lottspeich F, Overath P (1995). Ser/Thr-rich repetitive motifs as targets for phosphoglycan modifications in Leishmania mexicana secreted acid phosphatase. EMBO J, 14: 1067-74.
9. Symons FM, Murray PJ, Ji H, Simpson RJ, et al (1994). Characterization of a polymorphic family of integral membrane proteins in promastigotes of different Leishmania species. Mol Biochem Parasitol, 67: 103-13.
10. Lovelace JK, Gottlieb M (1986). Comparison of extracellular acid phosphatases from various isolates of Leishmania. Am J Trop Med Hyg, 35: 1121-28.
11. Jardim A, Tolson DL, Turco SJ, Pearson TW, Olafson RW (1991). The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. J Immunol, 147: 3538-44.
12. Russo DM, Turco SJ, Burns JM, Reed SG (1992). Stimulation of human T lympho-cytes by Leishmania lipophosphoglycan- associated proteins. J Immunol, 148: 202-7.
13. Ilg T, Stierhof YD, Craik D, Simpson R, Handman E, Bacic A (1996). Purification and structural characterization of a filamentous, mucin-like proteophosphoglycan secreted by Leishmania parasites. J Biol Chem, 271: 21583-96.
14. Sadick MD, Raff HV (1985). Differences in expression and exposure of promastigote and amastigote membrane molecules in Leishmania tropica. Infect Immun, 47: 395-400.
15. Dwyer DM, Langreth SG, Dwyer NK (1974). Evidence for a polysaccharide surface coat in the development stages of Leishmania donovani: a fine structure-cytochemical study. Z Parasitenkd, 43: 227-49.
16. Murray HW, Rubin BY, Rothermel CD (1983). Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: evidence that IFN-γ is the activating lymphokine. J Clin Invest, 72: 1506-10.
17. Convit J, Ulrich M, Fernandez CT, et al. (1993). The clinical and immunological spectrum of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg, 87: 444-48.
18. Kane MM, Mosser DM (2001). The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol, 166: 1141-47.
19. Vieth M, Will A, Schröppel K, Röllinghoff M, Gessner A (1994). Interleukin-10 inhibits antimicrobial activity against Leishma-nia major in murine macrophages. Scan J Immunol, 40: 403-09.
20. Rocha PN, Almeida RP, Bacellar O, De Jesus AR, Filho DC, Filho AC, et al. (1999). Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infec Dis, 180: 1731-34.
21. Adams LB, Hibbs JB, Taintor RR, Krahenbuhl J (1990). Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: Role for synthesis of inorganic nitrogen oxides from L-arginine. J Im-munol, 144: 2725-29.
22. Green SJ, Meltzer MS, Hibbs JB, Nacy CA (1990). Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol, 144: 278-83.
23. Liew FY, Millott S, Parkinson RMJ, Moncada S (1990). Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol, 44: 4794-97.
24. Green SJ, Scheller LF, Marletta MA, Segun MC, Klotz FW, Slayter M et al. (1994). Nitric oxide: Cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol Lett, 43: 87-94.